Combined treatment with Alhagi maurorum and docetaxel inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vivo

Combined treatment with Alhagi maurorum and docetaxel inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vivo

Breast cancer is a challenging disease and leading cause of cancer death in women. There is no effective agent for metastatic breast cancer after surgery and chemotherapy. Alhagi maurorum (A.m) has been reported to exhibit an anticancer effect on various types of cancer cells in vitro. This study ai...

Full description

Bibliographic Details
Main Authors: Nayereh Bahamin, Mahmoud Rafieian-Kopaei, Shahin Ahmadian, Iraj Karimi, Amir Hossein Doustimotlagh, Gholamreza Mobini, Elham Bijad, Mahshid Shafiezadeh
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Breast cancer
A. maurorum
Docetaxel
Angiogenesis
Synergy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023034990

Similar Items

Similar Items